Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of lactate and bicarbonate, typically administered as their sodium salts (sodium lactate and sodium bicarbonate), used as alkalinizing agents to correct metabolic acidosis. Lactate is metabolized in the liver to bicarbonate, providing an indirect source of base, while bicarbonate directly neutralizes excess hydrogen ions in the blood. This combination may be considered for prevention or control of mild to moderate metabolic acidosis when oral intake is restricted and oxidative metabolism is intact. However, it is not recommended for severe acidotic states requiring immediate correction or for lactic acidosis itself, as both agents have specific limitations and risks depending on underlying pathophysiology[3][5][6]. The mechanism involves buffering excess acid by increasing plasma bicarbonate concentration (bicarbonate) and hepatic conversion of lactate to bicarbonate (lactate).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactate + bicarbonate.